Why Viking Therapeutics Inc. (VKTX) Went Down on Monday
We recently published an article titled These 10 Companies Led Monday’s Downturn. In this article, we are going to take a ...
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
Viking Therapeutics VKTX has outperformed the market over the past 5 years by 22.07% on an annualized basis producing an ...
William Blair Issues Negative Outlook for VKTX Earnings
Equities researchers at William Blair decreased their Q1 2025 earnings per share estimates for shares of Viking Therapeutics in a research note issued to investors on Wednesday, February 5th. William ...
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NYSE: NVO), famously the company behind Wegovy, and ...
Bernstein Reaffirms Their Hold Rating on Novo Nordisk (0QIU)
In a report released today, Florent Cespedes from Bernstein maintained a Hold rating on Novo Nordisk (0QIU – Research Report), with a price ...
Investor's Business Daily on MSN5h
Gilead Soars Into Buy Zone After Obliterating Fourth-Quarter Expectations
Gilead stock popped late Tuesday after the company obliterated fourth-quarter expectations Tuesday and issued an upbeat ...
Eli Lilly & Co (LLY) Gets a Buy from Truist Financial
Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price ...
Investor's Business Daily on MSN6h
Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.
Despite "another impressive quarterly revenue beat" on Tuesday and solid guidance, Vertex stock dipped on light profit.